264 related articles for article (PubMed ID: 28229275)
1. A pilot randomized trial to prevent sexual dysfunction in postmenopausal breast cancer survivors starting adjuvant aromatase inhibitor therapy.
Advani P; Brewster AM; Baum GP; Schover LR
J Cancer Surviv; 2017 Aug; 11(4):477-485. PubMed ID: 28229275
[TBL] [Abstract][Full Text] [Related]
2. Effect of Fractional Carbon Dioxide vs Sham Laser on Sexual Function in Survivors of Breast Cancer Receiving Aromatase Inhibitors for Genitourinary Syndrome of Menopause: The LIGHT Randomized Clinical Trial.
Mension E; Alonso I; Anglès-Acedo S; Ros C; Otero J; Villarino Á; Farré R; Saco A; Vega N; Castrejón N; Ordi J; Rakislova N; Tortajada M; Matas I; Gómez S; Ribera L; Castelo-Branco C
JAMA Netw Open; 2023 Feb; 6(2):e2255697. PubMed ID: 36763359
[TBL] [Abstract][Full Text] [Related]
3. Intravaginal Testosterone Improves Sexual Satisfaction and Vaginal Symptoms Associated With Aromatase Inhibitors.
Davis SR; Robinson PJ; Jane F; White S; White M; Bell RJ
J Clin Endocrinol Metab; 2018 Nov; 103(11):4146-4154. PubMed ID: 30239842
[TBL] [Abstract][Full Text] [Related]
4. Aromatase Inhibitors Are Associated With Low Sexual Desire Causing Distress and Fecal Incontinence in Women: An Observational Study.
Robinson PJ; Bell RJ; Christakis MK; Ivezic SR; Davis SR
J Sex Med; 2017 Dec; 14(12):1566-1574. PubMed ID: 29066307
[TBL] [Abstract][Full Text] [Related]
5. The impact of endocrine therapy on sexual dysfunction in postmenopausal women with early stage breast cancer: encouraging results from a prospective study.
Frechette D; Paquet L; Verma S; Clemons M; Wheatley-Price P; Gertler SZ; Song X; Graham N; Dent S
Breast Cancer Res Treat; 2013 Aug; 141(1):111-7. PubMed ID: 23942873
[TBL] [Abstract][Full Text] [Related]
6. Vaginal estriol-lactobacilli combination and quality of life in endocrine-treated breast cancer.
Buchholz S; Mögele M; Lintermans A; Bellen G; Prasauskas V; Ortmann O; Grob P; Neven P; Donders G
Climacteric; 2015 Apr; 18(2):252-9. PubMed ID: 25427450
[TBL] [Abstract][Full Text] [Related]
7. Sexual problems during the first 2 years of adjuvant treatment with aromatase inhibitors.
Schover LR; Baum GP; Fuson LA; Brewster A; Melhem-Bertrandt A
J Sex Med; 2014 Dec; 11(12):3102-11. PubMed ID: 25141792
[TBL] [Abstract][Full Text] [Related]
8. Sexual Dysfunction in Survivorship; the Impact of Menopause and Endocrine Therapy.
Kuehn R; Casaubon J; Raker C; Edmonson D; Stuckey A; Gass J
Ann Surg Oncol; 2019 Oct; 26(10):3159-3165. PubMed ID: 31342358
[TBL] [Abstract][Full Text] [Related]
9. The acceptability, feasibility, and efficacy (phase I/II study) of the OVERcome (Olive Oil, Vaginal Exercise, and MoisturizeR) intervention to improve dyspareunia and alleviate sexual problems in women with breast cancer.
Juraskova I; Jarvis S; Mok K; Peate M; Meiser B; Cheah BC; Mireskandari S; Friedlander M
J Sex Med; 2013 Oct; 10(10):2549-58. PubMed ID: 23635341
[TBL] [Abstract][Full Text] [Related]
10. Comparing exercise responses to aerobic plus resistance training between postmenopausal breast cancer survivors undergoing aromatase inhibitor therapy and healthy women.
de Paulo TRS; Winters-Stone KM; Viezel J; Rossi FE; Aro BL; Trindade ACAC; Codogno JS; Freitas Junior IF
Disabil Rehabil; 2019 Sep; 41(18):2175-2182. PubMed ID: 29644889
[No Abstract] [Full Text] [Related]
11. The impact of aromatase inhibitors on sexual functioning: current knowledge and future research directions.
Mok K; Juraskova I; Friedlander M
Breast; 2008 Oct; 17(5):436-40. PubMed ID: 18479922
[TBL] [Abstract][Full Text] [Related]
12. Partner status moderates the relationships between sexual problems and self-efficacy for managing sexual problems and psychosocial quality-of-life for postmenopausal breast cancer survivors taking adjuvant endocrine therapy.
Dorfman CS; Arthur SS; Kimmick GG; Westbrook KW; Marcom PK; Corbett C; Edmond SN; Shelby RA
Menopause; 2019 Aug; 26(8):823-832. PubMed ID: 30994574
[TBL] [Abstract][Full Text] [Related]
13. A single-arm, prospective trial investigating the effectiveness of a non-hormonal vaginal moisturizer containing hyaluronic acid in postmenopausal cancer survivors.
Carter J; Baser RE; Goldfrank DJ; Seidel B; Milli L; Stabile C; Canty J; Saban S; Goldfarb S; Dickler MN; Gardner GJ; Jewell EL; Sonoda Y; Kollmeier MA; Alektiar KM
Support Care Cancer; 2021 Jan; 29(1):311-322. PubMed ID: 32358778
[TBL] [Abstract][Full Text] [Related]
14. Factors Associated With Specific Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Sexual Dysfunctions in Breast Cancer Survivors: A Study of Patients and Their Partners.
Hummel SB; Hahn DEE; van Lankveld JJDM; Oldenburg HSA; Broomans E; Aaronson NK
J Sex Med; 2017 Oct; 14(10):1248-1259. PubMed ID: 28923310
[TBL] [Abstract][Full Text] [Related]
15. A survey among breast cancer survivors: treatment of the climacteric after breast cancer.
Antoine C; Vandromme J; Fastrez M; Carly B; Liebens F; Rozenberg S
Climacteric; 2008 Aug; 11(4):322-8. PubMed ID: 18645698
[TBL] [Abstract][Full Text] [Related]
16. The relationship between anxiety and vaginal-related sexual health in postmenopausal breast cancer survivors on aromatase inhibitors therapies: a cross sectional study.
Bryl K; Chimonas S; Li X; Li SQ; Mao JJ
Breast Cancer Res Treat; 2023 Jul; 200(2):257-264. PubMed ID: 37226019
[TBL] [Abstract][Full Text] [Related]
17. Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer.
Baumgart J; Nilsson K; Evers AS; Kallak TK; Poromaa IS
Menopause; 2013 Feb; 20(2):162-8. PubMed ID: 22990756
[TBL] [Abstract][Full Text] [Related]
18. Sexual function after breast cancer.
Panjari M; Bell RJ; Davis SR
J Sex Med; 2011 Jan; 8(1):294-302. PubMed ID: 21199377
[TBL] [Abstract][Full Text] [Related]
19. Randomized Controlled Trial of a Home-Based Walking Program to Reduce Moderate to Severe Aromatase Inhibitor-Associated Arthralgia in Breast Cancer Survivors.
Nyrop KA; Callahan LF; Cleveland RJ; Arbeeva LL; Hackney BS; Muss HB
Oncologist; 2017 Oct; 22(10):1238-1249. PubMed ID: 28698390
[TBL] [Abstract][Full Text] [Related]
20. Tai chi for well-being of breast cancer survivors with aromatase inhibitor-associated arthralgias: a feasibility study.
Galantino ML; Callens ML; Cardena GJ; Piela NL; Mao JJ
Altern Ther Health Med; 2013; 19(6):38-44. PubMed ID: 24254037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
